Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVpc Specialty Regulatory News (VSL)

Share Price Information for Vpc Specialty (VSL)

Share Price is delayed by 15 minutes
Get Live Data
11.275    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 0.95 (8.796%)
Market Cap: £31.38m
VSL Live PriceLast checked at - London Stock Exchange

Intraday Vpc Specialty Share Chart

Acquisition

20 Dec 2021 11:29

RNS Number : 2112W
VPC Specialty Lending Invest. PLC
20 December 2021
 

VPC Specialty Lending Investments PLC (the "Company")

 Update Regarding its Holding in JAR Sponsor, LLC

 

The Company notes that on 20 December 2021, L&F Acquisition Corp. (NYSE: LNFA) ("LNFA"), a special purpose acquisition company sponsored by JAR Sponsor, LLC ("VPC Sponsor"), an affiliate of Victory Park Capital, announced it has entered into a definitive agreement to combine with ZeroFox (https://www.zerofox.com/). For more information on the transaction please see the ZeroFox and LNFA press release, which can be found here.

Through VPC Sponsor, the Company currently owns 130,220 Class B Shares and 167,284 private placement warrants in LNFA, held at an aggregate cost basis of US$168,051. The transaction implies an approximately US$1.4 billion post-merger pro forma equity value at a US$10.00 price per share of common stock.

Upon transaction closing, VSL's Class B Shares will automatically convert into one share of ZeroFox common stock. The aggregate undiscounted implied transaction value of the Class B Shares is US$1,302,200 to the Company. The Company's common stock shall be subject to a one-year post-closing lockup unless otherwise accelerated based on average trading performance measured on a rolling consecutive thirty-day period commencing at least 150 days post-closing, with 70% vested immediately and the remaining 30% subject to a five year vesting period from transaction close. One-third of the unvested shares will vest sooner if the volume weighted average price ("VWAP") per share reaches the following levels for 20 out of 30 trading days at any time during the five years: US$12.50, US$15.00 and US$17.50. The Company will initially value the common stock at a 30% discount to the closing trade price to account for deal closing risk, vesting and illiquidity due to the lock up on the common stock. The discounted valuation above results in a value of US$911,540 representing a 0.19% (0.24p) increase to the 31 October 2021 NAV (before fees).

Similarly, each private placement warrant converts into a warrant to purchase one share of common stock of ZeroFoxThe Company holds 167,284 warrants, which maintain a US$11.50 per share strike price, provide for cashless exercise and expire five years after closing of the transaction. The private placement warrants are valued utilising an option pricing model/Black Sholes model. The initial valuation of the private placement warrants at transaction close is US$266,651 representing a 0.2% (0.03p) increase to the 31 October 2021 NAV (before fees).

The transaction is expected to close in the second quarter of 2022 and remains subject to LNFA shareholder approval amongst other closing conditions. 

 

Enquiries

 

For further information, please contact:

 

Victory Park Capital

Brendan Carroll (Senior Partner and Co-Founder)

Gordon Watson (Partner)

 

via Jefferies or Winterflood (below)

info@vpcspecialtylending.com

 

Jefferies International Limited

 

Tel: +44 20 7029 8000

Stuart Klein

Neil Winward

Gaudi le Roux

 

 

Winterflood Securities Limited

Tel: +44 20 3100 0000

Neil Morgan

Chris Mills

 

Link Company Matters Limited (Company Secretary)

 

Tel: +44 20 7954 9567

Email: VPC@linkgroup.co.uk

 

 

 

About VPC Specialty Lending Investments PLC

VPC Specialty Lending Investments PLC (Company No. 9385218) is a UK listed investment trust focused on asset-backed lending to emerging and established businesses with the goal of building long-term, sustainable income generation. The Company identifies investment opportunities across various industries and geographies to offer shareholders access to a diversified portfolio of opportunistic credit investments originated by non-bank lenders with a focus on the rapidly developing technology-enabled lending sector.

 

Further information on VPC Specialty Lending Investments PLC is available at: http://vpcspecialtylending.com.

 

LEI: 549300UPEXC5DQB81P34

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ACQFLFFLFRLIFIL
Date   Source Headline
13th Nov 20247:00 amRNSDividend Declaration
29th Oct 202410:40 amRNSReappointment of PwC
8th Oct 20249:41 amRNSNet Asset Value(s)
24th Sep 20242:32 pmRNSChange to Directors' Responsibilities
20th Sep 20247:00 amRNSHalf-year Report
10th Sep 20247:00 amRNSNet Asset Value(s)
29th Aug 20247:00 amRNSDividend Declaration
13th Aug 20247:00 amRNSUpdate Regarding Investment Manager
8th Aug 20247:00 amRNSNet Asset Value(s)
10th Jul 20247:00 amRNSNet Asset Value(s)
13th Jun 20247:00 amRNSDividend Declaration
12th Jun 20246:21 pmRNSResult of AGM
12th Jun 20247:05 amRNSQuarterly Presentation
12th Jun 20247:00 amRNSNet Asset Value(s)
6th Jun 20245:26 pmRNSAppointment of Directors
20th May 20247:00 amRNSNet Asset Value(s)
2nd May 20244:27 pmRNSNotice of AGM
24th Apr 20247:00 amRNSAnnual Financial Report
22nd Apr 20247:00 amRNSNet Asset Value(s)
17th Apr 20244:30 pmRNSInitial Return of Capital Exchange Ratio
9th Apr 20247:00 amRNSInitial Return of Capital through B Share Scheme
5th Apr 202411:23 amRNSResult of General Meeting
15th Mar 20247:00 amRNSPublication of circular relating to B share scheme
8th Mar 20243:00 pmRNSNet Asset Value(s)
22nd Feb 20248:54 amRNSReplacement - Dividend Declaration
22nd Feb 20247:00 amRNSDividend Declaration
7th Feb 20249:00 amRNSNet Asset Value(s)
17th Jan 20247:00 amRNSNet Asset Value(s)
8th Dec 20237:00 amRNSNet Asset Value(s)
17th Nov 20237:00 amRNSDividend Declaration
13th Nov 20237:00 amRNSNet Asset Value and Monthly Report
5th Oct 20237:00 amRNSNet Asset Value and Monthly Report
29th Sep 20237:00 amRNSHalf-year Report
6th Sep 20237:00 amRNSNet Asset Value and Monthly Report
24th Aug 20237:00 amRNSDividend Declaration
8th Aug 20231:21 pmRNSNet Asset Value and Monthly Report
13th Jul 202311:45 amRNSNet Asset Value(s) and Monthly Report
26th Jun 20237:00 amRNSDividend Declaration
23rd Jun 20235:08 pmRNSResult of AGM
12th Jun 20235:31 pmRNSResult of Meeting
7th Jun 20237:00 amRNSNet Asset Value(s)
31st May 20231:26 pmRNSDirectorate Change and Notice of AGM
16th May 20232:58 pmRNSCircular containing a Notice of General Meeting
11th May 202310:07 amRNSNet Asset Value(s)
28th Apr 20237:00 amRNSAnnual Financial Report
11th Apr 20235:33 pmRNSHolding(s) in Company
6th Apr 20237:00 amRNSNet Asset Value(s)
7th Mar 20237:00 amRNSNet Asset Value(s)
22nd Feb 20237:00 amRNSDividend Declaration
10th Feb 20237:00 amRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.